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ABSTRACT 
Background; Macroscopic haematuria is a commonly seen condition in the emergency department (ED), which 
has a variety of causes. This study was performed to ascertain frequency of macroscopic hematuria among 
patients undergoing native renal biopsy using free hands ultrasound assisted renal biopsy technique within first 
24 hours, as there is no such study done in Pakistan on this topic. Objective: To determine frequency of 
macroscopic haematuria after native renal biopsy using free hands ultrasound assisted renal biopsy technique 
within first 24hours. Material and Methods: A total of 138 patients from Department of Nephrology; Shalamar 
hospital, Lahore, Pakistan were taken for macroscopic hematuria. Data was analyzed by SPSS. Results; Of these 
138 study cases, 91 (65.9 %) were male patients while 47 (34.1%) were female patients. Mean age of our study 
cases was 47.57 ± 7.26 years (with minimum age of our study cases was 35 years while maximum age was 60 
years). Of these 138 study cases, 56 (40.6%) belonged to rural areas and 82 (59.4%) belonged to urban areas. 
Monthly family income up to Rs. 350000 was noted in 67 (48.6%) while more than 35000 rupees 71 (51.4%) of 
our study cases. Obesity was present in 41 (29.7 %) of our study cases. Chronic kidney disease (un-explained 
renal failure) was noted in 77 (55.8%), proteinuria in 46(33.3%) and unresolved AKI in 15 (10.9%) of our study 
cases. Mean needle size was noted 17.15 ± 0.59 and 86 (62.3%) had needle size with gauge 18. Macroscopic 
hematuria was noted in 30 (21.7%) of our study case.  
Conclusion; High frequency of macroscopic hematuria after native renal biopsy using free hands ultrasound 
assisted renal biopsy technique was noted in our study.  Macroscopic hematuria was significantly associated 
with male gender, increasing age, residential status, monthly family income and indications for renal biopsy. The 
early diagnosis followed by corrective/preventive measures can help decrease disease morbidity among targeted 
population. This will help decrease disease burden and improve quality of life of these patients.  
Keywords; Macroscopic Hematuria, Native Renal Biopsy, Chronic Kidney Disease.  
 
INTRODUCTION: 
Percutaneous needle biopsy of the kidney is one of the most important investigations in assessing renal 
pathology 
1
. More recent studies have suggested that the renal biopsy identifies a diagnosis different from 
that predicted on clinical grounds in 50% to 60% of patients and leads to a treatment change in 20% to 50%
2
. 
Percutaneous renal biopsies were first performed by Iversen and Brun who used an aspiration biopsy 
needle
3
.Technical advances in biopsy procedures have changed from a blind approach to real time 
ultrasound guided techniques
4
. Several techniques have been used to perform renal biopsies. The most 
common are real time ultrasound-guided renal biopsy and free-hands ultrasound-assisted renal biopsy 
techniques. Nowadays, a real time ultrasound guided method has become the standard technique
5,6 
which has 
a diagnostic yield of 95% and significant complication rate of <5%
7.
 
Journal of Medicine, Physiology and Biophysics                                                                                                                              www.iiste.org 
ISSN 2422-8427     An International Peer-reviewed Journal 
Vol.51, 2018 
 
76 
 
As any invasive procedure, renal biopsy carry the risk of several complications, like 
pain, infection, renal damage or renal loss and bleeding. Bleeding complications can present with gross 
haematuria , peri-renal hematoma or formation of arterio-venous fistulas
8
. Bleeding may occur in 3 
distinct locations within the kidney: into the collecting system where it can present haematuria or 
obstruction , under the renal capsule and into the perinephric space causing hematoma formation presenting 
as severe loin pain and hypertension.Both visible haematuria and painful hematoma are seen in 3% to 4% 
of patients after biopsy
9
.Some studies advocate the risk of macroscopic haematuria 1 in 10 patient 
undergoing percutaneous renal biopsy
10
.The mean decrease in haemoglobin after a biopsy is 
approximately 1 g/ dl
11
.Most of the bleeding complications stated above occur within a period of 24 
hours
12
 
after renal biopsy. 
Despite the high frequency of performing renal biopsies , the exact rate of bleeding 
complications is still obscure
13
. Many data are collected before performing a renal biopsy, trying to 
predict post biopsy bleeding like blood pressure, haemoglobin, bleeding time, prothrombin time and 
coagulation profile. Few studies have examined the bleeding complications rate of percutaneous 
ultrasound guided biopsies using spring loaded devices and most of these studies have focused on this 
procedure using different needles
14
. Available data on macroscopic haematuria after percutaneous renal 
biopsy has been obtained from studies conducted in developed countries with more expertise in skill and 
equipment which obviously does not reflect population of developing world. 
 
MATERIALS AND METHODS 
Patient (n = 138) having age more than or equal to 12 years and less than or equal to 60 years presenting 
with significant proteinuria, isolated microscopic haematuria, unexplained renal failure with normal sized 
kidneys and unresolved AKI. Patients already having bleeding diathesis i.e. prothrombin time > 1.2 times 
normal, or activated thromboplastin time >1.2 times normal or bleeding time > 10 minutes or platelets 
count less than 100,000 or patient taking aspirin,clopidogrel or warfarin within 7 days or NSAIDS or 
subcutaneous heparin within last 24 hrs before renal biopsy. Patients having uncontrolled 
hypertension i.e. diastolic blood pressure of more than 95mm Hg, patient with solitary kidney on 
ultrasound. Urinary tract infection more than 10 pus cells on urinalysis, small kidneys(size less than 
9cm), anatomical abnormalities on ultrasound like horse shoe kidneys which may increase the 
risk to the patient, post-renal transplant patients, Multiple bilateral renal cysts or renal carcinoma and 
hydronephrotic kidneys on ultrasound were excluded from our study. 
Patient was put in prone position and lower pole of left kidney was marked using ultrasound machine. 
Renal biopsy puncture site was sterilised using pyodine solution and area was infiltrated with local 
anaesthetic lignocaine. After that renal biopsy was performed using automatic renal biopsy gun with 
calibre of 16 to18 gauge. Maximum of four passes was performed to get maximum of two cores for 
adequacy. Post-renal biopsy monitoring was done for initial 24 hours at least or according to patient’s 
situation. Patient was advised to collect urine for first 24 hours in a clean transplant container which was 
looked for evidence of macroscopic haematuria in day light. Cases was selected from Nephrology 
Department Shalamar Hospital Lahore, Pakistan. Data was analysed by using SPSS version 18 by 
researcher.  
RESULTS; 
Our study comprised of a total of 138 patients meeting inclusion criteria of our study. Of these 138 study cases, 
91 (65.9 %) were male patients while 47 (34.1%) were female patients. Mean age of our study cases was 47.57 ± 
7.26 years (with minimum age of our study cases was 35 years while maximum age was 60 years). Mean age of 
the male patients was noted to be 48.24 ± 6.73 years while that female patients was 46.26 ± 8.12 years 
(p=0.129). Our study results have indicated that majority of our study cases i.e. 107(77.5 %) were aged more 
than 40 years. Of these 138 study cases, 56 (40.6%) belonged to rural areas and 82 (59.4%) belonged to urban 
areas. Monthly family income up to Rs. 350000 was noted in 67 (48.6%) while more than 35000 rupees 71 
(51.4%) of our study cases. Mean body mass index of our study cases was 25.67 ± 2.23 kg/m
2 
and obesity was 
present in 41 (29.7 %) of our study cases. Chronic kidney disease (un-explained renal failure) was noted in 77 
(55.8%), proteinuria in 46(33.3%) and unresolved AKI in 15 (10.9%) of our study cases. Mean needle size was 
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noted 17.15 ± 0.59 and 86 (62.3%) had needle size with gauge 18. Macroscopic hematuria was noted in 30 
(21.7%) of our study case.  
Table No. 1 
Stratification of macroscopic hematuria with regards to gender. 
(n = 138) 
Gender 
Macroscopic hematuria 
P – value  Yes 
(n=30) 
No 
(n=108) 
Male 
(n=91) 
25 66 
0.029 
Female 
(n=47) 
05 42 
Total 138 
 
Table No. 2 
Stratification of Macroscopic hematuria with regards to age. 
(n = 138) 
Age 
Macroscopic hematuria 
P – value  Yes 
(n=30) 
No 
(n=108) 
Up to 40 Years 
(n=31) 
00 31 
0.000 
More than 40 Years 
(n=107) 
30 77 
 
Total 
 
138 
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Table No. 3 
Stratification of Macroscopic hematuria with regards to indications for biopsy. 
(n = 138) 
Indications 
Macroscopic hematuria 
P – value  Yes 
(n=30) 
No 
(n=108) 
CKD 
(n=77) 
25 52 
0.000 
Proteinuria  
(n=46) 
00 46 
Unresolved AKI 
(n=15) 
05 10 
 
Total 
 
138 
 
DISCUSSION; 
The majority of patients presenting with macroscopic haematuria can be managed on an outpatient basis, with 
follow‐up arranged under the 2‐week cancer target. However, there are some situations in which patients would 
be more appropriately managed as an inpatient under a urological team. Our study comprised of a total of 138 
patients meeting imulnclusion criteria of our study. Of these 138 study cases, 91 (65.9 %) were male patients 
while 47 (34.1%) were female patients. Siddiqui et al 
15 
reported 67 % male gender predominance which is in 
consistent with that of our study results. A study conducted by Iftikhar et al 
16
 from Lahore has reported 58 % 
male gender predominance, which is in compliance with that of our study findings. A study from Saudi Arabia 
17
 
has also reported male gender predominance in 61 % male patients, which is similar to that of our study results. 
Machingura et al 
18
 from Zimbabwe has reported male gender predominance in 70 % patients with ESRD on 
hemodialysis, these findings are close to that of our study results. Menon et al 
19
 also reported 58 % male gender 
predominance which is close to our study results.  
Mean age of our study cases was 47.57 ± 7.26 years (with minimum age of our study cases was 35 years while 
maximum age was 60 years). Mean age of the male patients was noted to be 48.24 ± 6.73 years while that female 
patients was 46.26 ± 8.12 years (p=0.129). Our study results have indicated that majority of our study cases i.e. 
107(77.5 %) were aged more than 40 years. Siddiqui et al from Rawalpindi 
11 
has reported 44.5 ±  14.3 years 
mean age of ESRD patients on hemodialysis. A study conducted in Lahore by Anees et al 
20
 has reported 46.10 ± 
16.29 years mean age of patients on hemodilaysis, these findings are close to that of our study results. 
Machingura et al 
18
 reported 46.7 ± 13.5 years mean age of these patients of ESRD on hemodialysis, these 
findings are close to that of our study results.  
Of these 138 study cases, 56 (40.6%) belonged to rural areas and 82 (59.4%) belonged to urban areas. Monthly 
family income up to Rs. 350000 was noted in 67 (48.6%) while more than 35000 rupees 71 (51.4%) of our study 
cases. Mean body mass index of our study cases was 25.67 ± 2.23 kg/m
2 
and obesity was present in 41 (29.7 %) 
of our study cases. Chronic kidney disease (un-explained renal failure) was noted in 77 (55.8%), proteinuria in 
46(33.3%) and unresolved AKI in 15 (10.9%) of our study cases.  Brustein et al 
11 
has also documented 48 % 
proteinuria which is close to our study results.
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Mean needle size was noted 17.15 ± 0.59 and 86 (62.3%) had needle size with gauge 18. Macroscopic hematuria 
was noted in 30 (21.7%) of our study case. Some studies have reported macroscopic hematuria to be present 
around 10 among patient undergoing percutaneous renal biopsy
10
. However our study results have reported 
slightly higher levels of macroscopic hematuria. 
 
CONCLUSION; 
High frequency of macroscopic haematuria after native renal biopsy using free hands ultrasound 
assisted renal biopsy technique was noted in our study.  Macroscopic hematuria was significantly associated 
with male gender, increasing age, residential status, monthly family income and indications for renal biopsy. The 
early diagnosis followed by corrective/preventive measures can help decrease disease morbidity among targeted 
population. This will help decrease disease burden and improve quality of life of these patients.  
 
REFERENCES 
1. Hanas E, Larsson E, Fellstrom B, Lindgren PG, Andersson T, Busch C, Frodin L, Wahlberg J, Tufveson G .Safety 
aspects and diagnostic fndings of serial renal allograft biopsies, obtained by an automatic technique with a midsize 
needle. Scand J Urol Nephrol.1992;26:413–420 
2. Kitterer D, Gurzing K,Sergey S, Alscher MD,Amann K,Braun N, et al. Diagnostic impact of percutaneous renal 
biopsy .Clin Nephrol .2015 Dec.84(12):311-22. 
3.  Iversen P, Brun C . Aspiration biopsy of the kidney. Am J Med.1951; 11:324–330 
4. Donovan KL, Thomas DM, Wheeler DC, Macdougall IC, Williams JD.Experience with a new method for 
percutaneous renal biopsy. Nephrol Dial Transplant.1991; 6:731–733 
5. Nass K, O’Neill C .Bedside renal biopsy: ultrasound guidance by the nephrologist. Am J Kidney Dis.1999;34:955–
959 
6. Kriegshauser JS ,Patella MD,Young SW, Chang YH,et al.Factors Contributing to the Success of Ultrasound-
Guided Native Renal Biopsy.J Ultrasound Med.2016 Feb. 35 (2):381-7. 
7. Hussain F, Mallik M, Marks SD, Watson AR. Nephrology on behalf of the BA of P. Renal biopsies in children: 
current practice and audit of outcomes. Nephrol Dial Transplant. 2010;25(2):485–9. 
8. Meldelssohn DC, Cole EH.Outcomes of percutaneous kidney biopsy, including those of solitary native kidney. 
Am J Kidney Dis.1995; 26:580–585 
9. Corapi KM, Chen JL, Balk EM, et al. Bleeding complications of  native kidney biopsy: A systematic review 
and  meta-analysis.  Am  J  Kidney  Dis. 2012;60: 62-73. 
10. Alan D.Salama,H.Terence Cook.The Kidney Biopsy .In:Karl Skorecki,Glenn M.Chertone,Philip  
A.Marsden,Martin  W.Taal,Alan  S.L.Yu,Walter  G.Wesser,editors 
11. Brenner and Rector’s The Kidney,10th Ed. Philadelphia ;Elsevier ;2016.p.915-925 
12.  Burstein DM, Korbet SM, Schwartz MM. The use of the automatic core biopsy system in percutaneous renal 
biopsies: A comparative study. Am J Kidney Dis. 1993;22:545-552. 
13. Marvah DS, Korbet SM.Timing of complications in percutaneous renal biopsy: What is the optimal period of 
observation? Am J Kidney Dis.1996;28:47–52 
14. Kim D, Kim H, Shin G et al. A randomized, prospective, comparative study of manual and automated renal 
biopsies. Am J Kidney Dis.1998; 32:426–431 
15.  Siddiqui UA, Halim A, Hussain T.  Nutritional profile and inflammatory status of stable chronic hemodialysis patients 
at nephrology department, Military hospital Rawalpindi. J Ayub Med Coll Abottabad 2007;19(4):29-31. 
16. Iftikhar U, Anees M, Nadeem M, Aman S,  Kazmi AH. Frequency of cutaneous manifestations in patients of end stage 
renal disease on haemodialysis. Ann King Edward Med Uni 2015;21(2):61-6. 
17. Gazzaz ZJ,  Dhafar KO, Tashkandi MA, Farooq MU.  
Clinical profile of haemodialysis patients with diabetic nephropathy leading to end stage renal disease. Pak J Med 
Sci 2010;26(1):82-7.  
18. Machingura PI1, Mahiya NM1, Chikwasha V2. Hypoalbuminaemia in haemodialysis patients at Parirenyatwa group of 
hospitals and Chitungwiza central hospital. Pan Afr Med J. 2015 Jun 1;21:79. doi: 10.11604/pamj.2015.21.79.4171. 
eCollection 2015. 
19. Menon V1, Greene T, Wang X, Pereira AA, Marcovina SM, Beck GJ, et al.  C-reactive protein and albumin as 
predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int. 2005 Aug;68(2):766-72. 
20. Anees M, Asim Mumtaz, Sumaira Frooqi, Ibrahim M, Farooq Hameed.  
Serum trace elements (aluminium, copper, zinc) in hemodialysis patients. Biomedica 2011;27(2):106-10.  
